» Articles » PMID: 30502051

Abnormal Brown Adipose Tissue Mitochondrial Structure and Function in IL10 Deficiency

Abstract

Background: Inflammation is the most relevant mechanism linking obesity with insulin-resistance and metabolic disease. It impacts the structure and function of tissues and organs involved in metabolism, such as the liver, pancreatic islets and the hypothalamus. Brown adipose tissue has emerged as an important component of whole body energy homeostasis, controlling caloric expenditure through the regulation of non-shivering thermogenesis. However, little is known about the impact of systemic inflammation on the structure and function of brown adipose tissue.

Methods: The relations between IL10 and mitochondria structure/function and also with thermogenesis were evaluated by bioinformatics using human and rodent data. Real-time PCR, immunoblot, fluorescence and transmission electron microscopy were employed to determine the effect of IL10 in the brown adipose tissue of wild type and IL10 knockout mice.

Findings: IL10 knockout mice, a model of systemic inflammation, present severe structural abnormalities of brown adipose tissue mitochondria, which are round-shaped with loss of cristae structure and increased fragmentation. IL10 deficiency leads to newborn cold intolerance and impaired UCP1-dependent brown adipose tissue mitochondrial respiration. The reduction of systemic inflammation with an anti-TNFα monoclonal antibody partially rescued the structural but not the functional abnormalities of brown adipose tissue mitochondria. Using bioinformatics analyses we show that in both humans and mice, IL10 transcripts correlate with mitochondrial lipid metabolism and caspase gene expression.

Interpretation: IL10 and systemic inflammation play a central role in the regulation of brown adipose tissue by controlling mitochondrial structure and function. FUND: Sao Paulo Research Foundation grant 2013/07607-8.

Citing Articles

Better cardiometabolic/inflammatory profile is associated with differences in the supraclavicular adipose tissue activity of individuals with T2DM.

Bonfante I, Segantim H, Mendonca K, de Oliveira M, Monfort-Pires M, Duft R Endocrine. 2024; 87(3):1011-1021.

PMID: 39627400 DOI: 10.1007/s12020-024-04122-6.


Defining Mitochondrial Cristae Morphology Changes Induced by Aging in Brown Adipose Tissue.

Crabtree A, Neikirk K, Marshall A, Vang L, Whiteside A, Williams Q Adv Biol (Weinh). 2023; 8(1):e2300186.

PMID: 37607124 PMC: 10869235. DOI: 10.1002/adbi.202300186.


Defining Mitochondrial Cristae Morphology Changes Induced by Aging in Brown Adipose Tissue.

Crabtree A, Neikirk K, Marshall A, Vang L, Whiteside A, Williams Q bioRxiv. 2023; .

PMID: 37577723 PMC: 10418056. DOI: 10.1101/2023.05.12.540609.


Metabolic impact of adipose tissue macrophages in the early postnatal life.

Roszer T J Leukoc Biol. 2022; 112(6):1515-1524.

PMID: 35899927 PMC: 9796690. DOI: 10.1002/JLB.3MR0722-201R.


Regulation of mitochondrial temperature in health and disease.

El-Gammal Z, Nasr M, Elmehrath A, Salah R, Saad S, El-Badri N Pflugers Arch. 2022; 474(10):1043-1051.

PMID: 35780250 PMC: 9492600. DOI: 10.1007/s00424-022-02719-2.


References
1.
Rennick D, Fort M . Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2000; 278(6):G829-33. DOI: 10.1152/ajpgi.2000.278.6.G829. View

2.
Demerath E, Guo S, Chumlea W, Towne B, Roche A, Siervogel R . Comparison of percent body fat estimates using air displacement plethysmography and hydrodensitometry in adults and children. Int J Obes Relat Metab Disord. 2002; 26(3):389-97. DOI: 10.1038/sj.ijo.0801898. View

3.
van Exel E, Gussekloo J, de Craen A, Frolich M, Bootsma-van der Wiel A, Westendorp R . Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. Diabetes. 2002; 51(4):1088-92. DOI: 10.2337/diabetes.51.4.1088. View

4.
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R . Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37(4):917-23. DOI: 10.1053/jhep.2003.50161. View

5.
Kim H, Higashimori T, Park S, Choi H, Dong J, Kim Y . Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes. 2004; 53(4):1060-7. DOI: 10.2337/diabetes.53.4.1060. View